Dr Anthony Kong Academics Supervisors Reader and Honorary Consultant Clinical Oncologist Research subject areas Cancer Contact details +44 (0) 20 7848 8302 anthony.kong@kcl.ac.uk
Local radiotherapy and E7 RNA-LPX vaccination show enhanced therapeutic efficacy in preclinical models of HPV16 + cancer Salomon, N., Selmi, A., Grunwitz, C., Kong, A., Stanganello, E., Neumaier, J., Petschenka, J., Diken, M., Kreiter, S., Türeci, Ö., Sahin, U. & Vascotto, F., 31 Dec 2021, (E-pub ahead of print) In: Cancer immunology, immunotherapy : CII. Research output: Contribution to journal › Article › peer-review. DOIs: https://doi.org/10.1007/s00262-021-03134-9 A phase II study of monalizumab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: The I1 cohort of the EORTC-HNCG-1559 UPSTREAM trial Galot, R., Le Tourneau, C., Saada-Bouzid, E., Daste, A., Even, C., Debruyne, P., Henry, S., Zanetta, S., Rutten, A., Licitra, L., Canon, J. L., Kaminsky, M. C., Specenier, P., Rottey, S., Guigay, J., Kong, A., Tinhofer, I., Borcoman, E., Dirix, L., Raveloarivahy, T., & 5 othersFortpied, C., Vanlancker, M., Morfouace, M., Govaerts, A. S. & Machiels, J. P., Nov 2021, In: European Journal of Cancer. 158, p. 17-26 10 p. Research output: Contribution to journal › Article › peer-review. DOIs: https://doi.org/10.1016/j.ejca.2021.09.003 Centralised recist assessment and clinical outcomes with lenvatinib monotherapy in recurrent and metastatic adenoid cystic carcinoma Feeney, L., Jain, Y., Beasley, M., Donnelly, O., Kong, A., Moleron, R., Nallathambi, C., Rolles, M., Sanghera, P., Tin, A., Ulahannan, D., Walter, H. S., Webster, R. & Metcalf, R., 1 Sep 2021, In: Cancers. 13, 17, 4336. Research output: Contribution to journal › Article › peer-review. DOIs: https://doi.org/10.3390/cancers13174336 A multi-centre survey reveals variations in the standard treatments and treatment modifications for head and neck cancer patients during Covid-19 pandemic Vasiliadou, I., Noble, D., Hartley, A., Moleron, R., Sanghera, P., Urbano, T. G., Schipani, S., Gujral, D., Foran, B., Bhide, S., Haridass, A., Nathan, K., Michaelidou, A., Sen, M., Geropantas, K., Joseph, M., O'Toole, L., Griffin, M., Pettit, L., Chambers, J., & 6 othersJankowska, P., De Winton, E., Goranova, R., Singh, N., Shah, K. & Kong Conceptualisation, A., Sep 2021, In: Clinical and Translational Radiation Oncology. 30, p. 50-59 10 p. Research output: Contribution to journal › Article › peer-review. DOIs: https://doi.org/10.1016/j.ctro.2021.06.002 WEE1 Inhibitor: Clinical Development Kong, A. & Mehanna, H., Sep 2021, In: Current Oncology Reports. 23, 9, 107. Research output: Contribution to journal › Review article › peer-review. DOIs: https://doi.org/10.1007/s11912-021-01098-8 Comprehensive genomic and transcriptomic analysis of three synchronous primary tumours and a recurrence from a head and neck cancer patient Bresadola, L., Weber, D., Ritzel, C., Löwer, M., Bukur, V., Akilli-öztürk, Ö., Becker, J., Mehanna, H., Schrörs, B., Vascotto, F., Sahin, U. & Kong, A., 2 Jul 2021, In: International Journal of Molecular Sciences. 22, 14, 7583. Research output: Contribution to journal › Article › peer-review. DOIs: https://doi.org/10.3390/ijms22147583 Safety and treatment outcomes of nivolumab for the treatment of recurrent or metastatic head and neck squamous cell carcinoma: Retrospective multicenter cohort study Vasiliadou, I., Breik, O., Baker, H., Leslie, I., Sim, V. R., Hegarty, G., Michaelidou, A., Nathan, K., Hartley, A., Good, J., Sanghera, P., Fong, C., Urbano, T. G., Lei, M., Petkar, I., Ferreira, M. R., Nutting, C., Wong, K. H., Newbold, K., Harrington, K., & 2 othersBhide, S. & Kong, A., 2 Mar 2021, In: Cancers. 13, 6, p. 1-12 12 p., 1413. Research output: Contribution to journal › Article › peer-review. DOIs: https://doi.org/10.3390/cancers13061413 Looking a Gift Horse in the Mouth: Observations on NHS England's Interim Guidance on Pembrolizumab in Head and Neck Squamous Cell Cancer Harrington, K. J., Bhide, S. A., Forster, M. D., Good, J. S., Gunn, L., Kong, A., Melcher, A. A., Metcalf, R., Nenclares, P., Newbold, K. L., Nutting, C. M., Prestwich, R., Sacco, J. J., Soliman, H. & Wong, K. H., Aug 2020, In: Clinical Oncology. 32, 8, p. 490-492 3 p. Research output: Contribution to journal › Editorial › peer-review. DOIs: https://doi.org/10.1016/j.clon.2020.05.016 Talimogene Laherparepvec and Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (MASTERKEY-232): A Multicenter, Phase 1b Study Harrington, K. J., Kong, A., Mach, N., Chesney, J. A., Fernandez, B. C., Rischin, D., Cohen, E. E. W., Radcliffe, H-S., Gumuscu, B., Cheng, J., Snyder, W. & Siu, L. L., 15 Jul 2020, (E-pub ahead of print) In: Clinical cancer research : an official journal of the American Association for Cancer Research. Research output: Contribution to journal › Article › peer-review. DOIs: https://doi.org/10.1158/1078-0432.CCR-20-1170 Phase I trial of WEE1 inhibition with chemotherapy and radiotherapy as adjuvant treatment, and a window of opportunity trial with cisplatin in patients with head and neck cancer: The WISTERIA trial protocol Kong, A., Good, J., Kirkham, A., Savage, J., Mant, R., Llewellyn, L., Parish, J., Spruce, R., Forster, M., Schipani, S., Harrington, K., Sacco, J., Murray, P., Middleton, G., Yap, C. & Mehanna, H., 16 Mar 2020, In: BMJ Open. 10, 3, e033009. Research output: Contribution to journal › Article › peer-review. DOIs: https://doi.org/10.1136/bmjopen-2019-033009 View all publications
29 September 2021 Rare small animal irradiator part of School infrastructure Small animal irradiator for commencement of pre-clinical radiotherapy projects